Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition is a paper indexed in PICO Portal from OpenAlex.
How many citations does Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition have?
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition has 1,010 citations in the OpenAlex counts PICO Portal stores.
When was Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition published?
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition has 2016 year in the PICO Portal index.
What is the open-access status of Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition?
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition has green oa status in the PICO Portal index.
What is the DOI of Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition?
The DOI for Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition is on the source record.
What is the PMID of Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition?
The PMID for Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition is on the source record.
What is the OpenAlex record for Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition?
The OpenAlex for Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition is on the source record.